Rising Stars in Retina: Jesse D. Sengillo, MD – Retina Today
Retina Today: When did you first know that you wanted to become a retina specialist? I had an early interest in the field of retina, and I even app
Retina Today: When did you first know that you wanted to become a retina specialist? I had an early interest in the field of retina, and I even app
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
This cross-sectional study compares the diagnostic accuracy and comprehensiveness of responses from a large language model chatbot with those of fellowship-trained glaucoma and retina specialists…
The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, Maryland.
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia
Rick Lewis, chief medical officer of ViaLase, describes the company’s nonincisional glaucoma treatment, showing promising safety and efficacy in studies and possibly paving the way…
Young ophthalmologists who attended Mid-Year Forum 2024 and met with their lawmakers on Capitol Hill also documented their activities on social media. Who did it…
During a recent symposia series, respected cataract surgeons explained the key advantages of performing cataract surgery with more physiologic IOP when using CENTURION® Vision System…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
Harrow’s Iheezo, a topical ocular anesthetic, is the first FDA-approved use of chloroprocaine hydrochloride in the US ophthalmic market.